ChemoMetec A/S (LON:0DZ0)
722.57
+30.90 (4.47%)
At close: Oct 27, 2025
ChemoMetec Revenue
In the fiscal year ending June 30, 2025, ChemoMetec had annual revenue of 495.57M DKK with 21.50% growth. ChemoMetec had revenue of 244.10M in the half year ending June 30, 2025, with 21.00% growth.
Revenue
495.57M DKK
Revenue Growth
+21.50%
P/S Ratio
26.80
Revenue / Employee
2.92M DKK
Employees
170
Market Cap
1.53B GBP
Revenue Chart
* This company reports financials in DKK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 495.57M | 87.70M | 21.50% |
| Jun 30, 2024 | 407.87M | -36.53M | -8.22% |
| Jun 30, 2023 | 444.40M | 16.01M | 3.74% |
| Jun 30, 2022 | 428.39M | 147.26M | 52.38% |
| Jun 30, 2021 | 281.13M | 67.03M | 31.31% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 198.54B |
| BP p.l.c. | 134.89B |
| Unilever | 51.24B |
| AstraZeneca | 41.24B |
| HSBC Holdings | 41.03B |
| Rio Tinto Group | 39.22B |
| GSK plc | 31.63B |
| British American Tobacco p.l.c. | 25.60B |